MLANA

MLANA (Melan-A), also known as Melanoma Antigen Recognized by T-cells 1 (MART-1), is a protein that in humans is encoded by the MLANA gene. MLANA is primarily recognized for its role in the immune system's response to melanoma, a type of skin cancer. It is considered a tumor antigen, which are substances produced by tumor cells that can be recognized by the immune system, potentially leading to an immune response against the tumor.

Function

MLANA is involved in the melanin biosynthetic process, contributing to the pigmentation of the skin, hair, and eyes. The protein is expressed in melanocytes, cells responsible for the production of melanin, and is used as a marker for melanocyte lineage. Its expression is not limited to malignant cells but is also found in normal melanocytes, although it is significantly upregulated in melanoma cells. This upregulation in melanoma and its limited expression in normal tissues make MLANA a target for immunotherapy and cancer vaccines.

Clinical Significance

MLANA is of particular interest in the field of oncology for its potential as a target for cancer immunotherapy. Since MLANA is predominantly expressed in melanoma cells, it serves as a biomarker for the diagnosis and prognosis of melanoma. Therapeutic strategies, including T-cell based therapies and vaccines, have been developed to target MLANA, aiming to boost the immune system's ability to recognize and destroy melanoma cells.

Immunotherapy

Immunotherapeutic approaches targeting MLANA seek to enhance the immune system's response against melanoma. These include the use of T-cell receptor (TCR) engineered T-cells and monoclonal antibodies that specifically target MLANA-expressing cells. Such therapies have shown promise in clinical trials, offering a potential treatment option for patients with advanced melanoma.

Genetic Studies

Research into the MLANA gene and its protein product has also provided insights into the genetic basis of melanoma. Studies have investigated the role of mutations within the MLANA gene and their impact on protein function and melanoma development. Understanding these genetic factors is crucial for the development of targeted therapies and personalized medicine approaches in melanoma treatment.

See Also

• Melanoma
• Immunotherapy
• Tumor antigen
• Melanocyte
• Cancer vaccine

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian